针灸减肥;肥胖悖论;无管胰岛素泵获批
Acupuncture for Weight Loss; The 'Obesity Paradox'; Tubeless Insulin Pump Cleared
一项随机试验显示针灸可导致中国超重或肥胖女性适度但持续的减重;FDA批准MiniMed无管胰岛素泵用于7岁及以上糖尿病患者;Senseonics和Beta Bionics推出集成Eversense 365的iLet Bionic胰岛素泵。
报道了多项临床研究结果和产业动态,为内分泌领域提供了最新进展。
— News and commentary from the endocrinology world
November 17, 2026 • 2 min read
Acupoint thread embedding -- a traditional Chinese medicine technique -- led to modest but sustained weight loss in Chinese women with overweight or obesity, a randomized trial showed. (Annals of Internal Medicine)
Ischemic optic neuropathy, gastroparesis, thyroid C-cell tumors, gallstones, pancreatitis, and more -- the Washington Post looked at some of the rare but serious side effects linked to GLP-1 receptor agonists.
A CVS Health analysis found that health plans could break even on GLP-1 drugs that cost under $350 per month, given the resulting savings from fewer emergency department visits and hospitalizations. (Reuters via AOL)
Findings from an international study supported the adoption of the Lancet Commission's new diagnostic definition of obesity to improve management and policy. (Nature)
A lower dose of investigational cagrilintide-semaglutide was better than placebo for reducing body weight in adults, according to phase III study results detailed in Lancet Diabetes & Endocrinology and at ObesityWeek. Catch up on more data from the annual meeting here.
The New York Times examined the "obesity paradox" -- why higher body weight sometimes correlates with better survival in certain conditions.
The FDA cleared MiniMed's tubeless insulin pump (MiniMed Fit) for people ages 7 years and older with type 1 or type 2 diabetes, the company announced.
Senseonics and Beta Bionics announced the launch of the iLet Bionic Pancreas integrated with the Eversense 365 continuous glucose monitoring system, which was designed to reduce the burden of diabetes management.
A deep learning model applied to routine chest x-rays outperformed the Fracture Risk Assessment Tool for predicting major osteoporotic fracture risk, offering the greatest benefit to patients with osteopenia. (NEJM AI)
Meanwhile, an Australian cohort study emulating a target trial suggested that nitrogen-containing bisphosphonates were associated with similar mortality rates to denosumab after a low-trauma fracture, but were also tied to a higher risk of refracture. (JAMA Network Open)
The Endocrine Society and the European Society of Endocrinology named pediatric endocrinologist Anders Juul, MD, PhD, as the recipient of their 2027 Transatlantic Alliance Award.
来源:MedPage Today · medpagetoday.com